We have developed a methodology of preparing explant livers for perfusion and vessel size imaging. Off-label use of ferumoxytol is known to provide high quality vessel size maps in vivo; however, known adverse reactions to ferumoxytol may hinder adoption into the clinical workflow. In this case, gadolinium may be more attractive. VSI experiments on a gadolinium perfused liver provide a proof of concept that Gadolinium may be used as an alternative contrast for vessel size imaging.
No takes yet. Share an insight, caveat, or question.
Romano et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: